NCT06360328 Success Rates of Video- vs. Direct Laryngoscopy for Endotracheal Intubation in Anesthesiology Residents: A Randomized Controlled Trial" (The JuniorDoc-VL-Trial)
| NCT ID | NCT06360328 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Heidelberg |
| Condition | Intubation Complication |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2027-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-04-01 with a primary completion date of 2027-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Securing the airway through endotracheal intubation (ETI) is a fundamental skill for anaesthetists. It is used during surgery, in the intensive care unit, during periprocedural anaesthesia and in emergency medicine. The clinical relevance of airway management is demonstrated in particular by the fact that the main cause of serious anaesthesia-related complications lies in the area of airway management. increasing technological developments in recent years (e.g. video laryngoscopy \[VL\]) aim to reduce the complication rate in the area of airway management. however, there are currently a large number of VLs available, which differ massively in their application. Therefore, it is essential to systematically collect data and develop structured training in airway management, taking into account current technological developments.While endotracheal intubation is traditionally performed with a direct laryngoscope, indirect video laryngoscopy, with chip-based camera technology at its tip, has been introduced across the board in recent years and is now part of standard clinical and preclinical equipment. Doctors in advanced training are trained with a focus on direct laryngoscopy; the use of and training in indirect video laryngoscopy does not follow any standards; in addition, the decision as to which method of securing the airway is chosen has so far been the responsibility of the individual doctor in anaesthesiology, although there is a tendency for the VL to be associated with a higher success rate in the first intubation attempt, the so-called "first-pass success".The main aim of this clinical prospective, randomised controlled trial is to train anaesthetists in advanced training in conventional direct laryngoscopy on the one hand and indirect video laryngoscopy (VL) on the other, with a focus on tracking the progress of their skills after 200 intubations with regard to first-pass success.
Eligibility Criteria
Inclusion Criteria: * First Year Anesthesiology Residents Exclusion Criteria: * Physicians' refusal to participate in the study * Participants in another study
Contact & Investigator
Davut Deniz Uzun, Dr. / MD
PRINCIPAL INVESTIGATOR
University of Heidelberg, Medical Faculty, Departement of Anesthesiology, Heidelberg, Germany
Frequently Asked Questions
Who can join the NCT06360328 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Intubation Complication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06360328 currently recruiting?
Yes, NCT06360328 is actively recruiting participants. Contact the research team at deniz.uzun@med.uni-heidelberg.de for enrollment information.
Where is the NCT06360328 trial being conducted?
This trial is being conducted at Heidelberg, Germany.
Who is sponsoring the NCT06360328 clinical trial?
NCT06360328 is sponsored by University Hospital Heidelberg. The principal investigator is Davut Deniz Uzun, Dr. / MD at University of Heidelberg, Medical Faculty, Departement of Anesthesiology, Heidelberg, Germany. The trial plans to enroll 30 participants.